Jay D. Kranzler, CEO at CYPRESS BIOSCIENCE INC (CYPB), sold 18,324 shares at $11.51 ($167K) on 2007-12-24, disclosed to the SEC on 2007-12-27.
Scheduled sale ($167k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 4,000 | $0 | 0.0% |
| 2 | $11.51 | 671 | $8K | 4.6% |
| 3 | $11.55 | 729 | $8K | 5.0% |
| 4 | $11.56 | 300 | $3K | 2.1% |
| 5 | $11.57 | 1,500 | $17K | 10.4% |
| 6 | $11.58 | 300 |
| $3K |
| 2.1% |
| 7 | $11.59 | 400 | $5K | 2.8% |
| 8 | $11.60 | 300 | $3K | 2.1% |
| 9 | $11.63 | 300 | $3K | 2.1% |
| 10 | $11.65 | 1,400 | $16K | 9.8% |
| 11 | $11.66 | 1,000 | $12K | 7.0% |
| 12 | $11.67 | 1,600 | $19K | 11.2% |
| 13 | $11.68 | 700 | $8K | 4.9% |
| 14 | $11.69 | 1,899 | $22K | 13.3% |
| 15 | $11.70 | 2,201 | $26K | 15.4% |
| 16 | $11.71 | 400 | $5K | 2.8% |
| 17 | $11.72 | 300 | $4K | 2.1% |
| 18 | $11.75 | 24 | $282 | 0.2% |
| 19 | $11.76 | 300 | $4K | 2.1% |
| Total | $9.10 avg | 18,324 | $167K | 100% |
| Filing → |
| CYPB | SELL | 2010-12-29 | $162K | — | Filing → |
| CYPB | SELL | 2010-12-29 | $983K | — | Filing → |
| CYPB | SELL | 2009-08-04 | $652K | — | Filing → |